(Q44425352)

2 December 2017

title

Detectability of hepatocellular carcinoma by gadoxetate disodium-enhanced hepatic MRI: tumor-by-tumor analysis in explant livers (English)

1 reference

2 December 2017

main subject

hepatocellular carcinoma

1 reference

4

Hideki Ohdan

1 reference

2 December 2017

2

Hirotaka Tashiro

1 reference

2 December 2017

7

Kazuo Awai

1 reference

2 December 2017

3

Junko Nambu

1 reference

2 December 2017

5

Hideaki Kakizawa

1 reference

2 December 2017

Yuko Nakamura

1

1 reference

2 December 2017

Shuji Date

series ordinal

6

1 reference

2 December 2017

publication date

10 October 2012

1 reference

Journal of Magnetic Resonance Imaging

2 December 2017

published in

1 reference

2 December 2017

volume

37

1 reference

2 December 2017

issue

3

1 reference

2 December 2017

page(s)

684-691

1 reference

Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23855

Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatoce

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23855

Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the Detection of hepatocellular carcinoma in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23855

Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23855

Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23855

Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23855

Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging--correlation with expression of sinusoidal and canalicular transporters and bile accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23855

Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23855

MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23855

Significance of hyperattenuating and contrast-enhancing hepatic nodules detected in the cirrhotic liver during arterial phase helical CT in pre-liver transplant patients: radiologic-histopathologic correlation of explanted livers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23855

Malignant focal hepatic lesions complicating underlying liver disease: dual-phase contrast-enhanced spiral CT sensitivity and specificity in orthotopic liver transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23855

Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23855

Pretransplantation diagnosis and staging of hepatocellular carcinoma in patients with cirrhosis: value of dual-phase helical CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23855

Liver parenchymal enhancement of hepatocyte-phase images in Gd-EOB-DTPA-enhanced MR imaging: which biological markers of the liver function affect the enhancement?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23855

Management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23855

Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23855

Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23855

Large (>or=2 cm) non-hypervascular nodules depicted on MRI in the cirrhotic liver: fate and implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23855

Nonhypervascular hypoattenuating nodules depicted on either portal or equilibrium phase multiphasic CT images in the cirrhotic liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23855

Multidetector-row computed tomography (MDCT) for the diagnosis of hepatocellular carcinoma in cirrhotic candidates for liver transplantation: prevalence of radiological vascular patterns and histological correlation with liver explants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23855

Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23855

Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23855

21 January 2018

Identifiers

DOI

10.1002/JMRI.23855

1 reference

2 December 2017

1 reference